Roche announces definitive agreement to acquire Seragon Pharmaceuticals
- Details
- Category: Roche
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that Genentech, a member of the Roche Group, has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc. (Seragon), a privately held biotechnology company based in San Diego, California, USA.
Amgen receives FDA Breakthrough Therapy Designation for investigational BiTE® antibody blinatumomab in acute lymphoblastic leukemia
- Details
- Category: Amgen
Amgen (NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to investigational bispecific T cell engager (BiTE®) antibody blinatumomab, for adults with Philadelphia-negative (Ph-) relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL), a rapidly progressing cancer of the blood and bone marrow(1).
Boehringer Ingelheim Statement on Hepatitis C drug development
- Details
- Category: Boehringer Ingelheim
Boehringer Ingelheim has re-evaluated its strategy in hepatitis C (HCV), and as a result the company has decided not to move forward in this therapeutic area. The HCV treatment environment has significantly and rapidly evolved since the submission of the faldaprevir marketing applications to regulatory bodies around the world.
James C. Smith elected to Pfizer's Board of Directors
- Details
- Category: Pfizer
Pfizer Inc. has announced the election of James C. Smith to its Board of Directors, effective immediately. Mr. Smith also was appointed to the Corporate Governance and Science and Technology Committees of Pfizer's Board.
Abbott to acquire Veropharm
- Details
- Category: Abbott
Abbott (NYSE: ABT) has announced a definitive agreement to acquire Veropharm, a leading Russian pharmaceutical manufacturer. Under the terms of the agreement, Abbott will acquire Limited Liability Company Garden Hills, the holding company that currently owns a controlling interest in Veropharm, for between 13.6 billion rubles and 17 billion rubles (or a range of approximately $395 million to $495 million U.S. dollars) depending on Garden Hills' share ownership of Veropharm at time of close.
Sanofi and Medtronic to form strategic alliance
- Details
- Category: Sanofi
Sanofi (EURONEXT: SAN and NYSE: SNY) and Medtronic, Inc. (NYSE: MDT) have signed a memorandum of understanding to enter into a global strategic alliance in diabetes, aimed at improving patient experience and outcomes for people with diabetes around the world.
Roche Children's Walk 2014
- Details
- Category: Roche
Roche employees at more than 120 company sites around the world have been showing their solidarity with children in need by raising funds through sponsored walks. The donations will be used to support day-care centers for orphans and educational initiatives in Malawi, as well as children's charities in their own countries.
More Pharma News ...
- Pfizer and Cellectis enter into global strategic cancer immunotherapy collaboration
- Pfizer opens new state-of-the-Art research and development site in Cambridge, Massachusetts
- Mindprint implements market-leading automation solution for Ockham Oncology
- Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC
- Bristol-Myers Squibb and Syngene International extend research collaboration
- AstraZeneca updates on the rapid progress of its oncology pipeline at ASCO 2014
- Bayer and Orion Corporation to develop and commercialize novel prostate cancer treatment